Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab
Joint Authors
Thomsen, Simon Francis
Lieberoth, Sofie
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-01-28
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remainson a palliative basis.
We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti-IgE) reduced gastrointestinal and cutaneous symptoms significantly.
This observation provides additional insight into the effects of omalizumab on systemic mastocytosis.
American Psychological Association (APA)
Lieberoth, Sofie& Thomsen, Simon Francis. 2015. Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab. Case Reports in Medicine،Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058928
Modern Language Association (MLA)
Lieberoth, Sofie& Thomsen, Simon Francis. Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab. Case Reports in Medicine No. 2015 (2015), pp.1-3.
https://search.emarefa.net/detail/BIM-1058928
American Medical Association (AMA)
Lieberoth, Sofie& Thomsen, Simon Francis. Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab. Case Reports in Medicine. 2015. Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058928
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058928
